France (FR)

Care for neuroendocrine tumor patients, monitored by medical oncologists: Comparative data Europe vs North America (2021) Kolarova T, Mcdonnell M, Bouvier CV, Pavel ME, Singh H, Howe J, Singh S, et al. Conference contribution Targeting of the Tec Kinase ITK Drives Resolution of T Cell–Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative Colitis (2021) Lechner-Grimm K, Mott S, Al-Saifi R, Knipfer L, Wirtz S, Atreya R, Vieth M, et al. Journal article Building trust in rural producer organizations: Results from a randomized controlled trial (2021) Bernard T, Dänzer PN, Frölich M, Landmann A, Viceisza A, Wouterse F Journal article Applied Reconfigurable Computing. Architectures, Tools, and Applications (2021) Derrien S, Hannig F, Diniz PC, Chillet D Conference contribution, other Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium (2021) Wiebe J, Hofmann FJ, West N, Baumbach A, Carrie D, Bermudez EP, Cayla G, et al. Journal article An X-ray interferometry concept for the ESA Voyage 2050 programme (2021) Uttley P, Den Hartog R, Bambi C, Barret D, Bianchi S, Bursa M, Cappi M, et al. Conference contribution Warm Front End Electronic Modelization for the X-IFU ATHENA Readout Chain Simulation (2021) Prele D, Chen S, Coleiro A, Varniere P, Peille P, Ravera L, Kirsch C Conference contribution Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms (2021) Hoertel N, Sanchez-Rico M, Cougoule C, Gulbins E, Kornhuber J, Carpinteiro A, Becker KA, et al. Journal article Towards robust, fast solutions of elliptic equations on complex domains through hybrid high-order discretizations and non-nested multigrid methods (2021) Di Pietro DA, Hulsemann F, Matalon P, Mycek P, Rüde U, Ruiz D Journal article Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies (2021) Giovannoni G, Comi G, Rammohan K, Rieckmann P, Dangond F, Keller B, Jack D, Vermersch P Journal article